Cegedim Sa · EURONEXT:ALCGM
Cegedim Sa — J.P. Morgan Healthcare Conference 2015
43 slides from Cegedim Sa's conference presentation, Jan 15, 2015
Slide 1: J.P. Morgan Healthcare Conference
J.P.Morgan Healthcare Conference 15 January 2015
Slide 2: Safe Harbor Statement
This presentation contains forward-looking statements (made pursuant to the safe harbour Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- Statement looking statements involve risk and uncertainty. Forward-looking statements represent the comp
Slide 3: Agenda
Cegedim Group Activities Agenda Financial Performance
Slide 4: Cegedim Group Activities
Cegedim Group Activities aig cegedim
Slide 5: Cegedim Today
Cegedim Today This document should not be distributed without Cegedim authorization – Copyright 2014 5
Slide 6: Two Different Strategies
Two Different Strategies This document should not be distributed without Cegedim authorization – Copyright 2014 6
Slide 7: Two Different Strategies
Two Different Strategies This document should not be distributed without Cegedim authorization – Copyright 2014 7
Slide 8: Definitive Purchase Agreement Executed
Definitive Purchase Agreement Executed This document should not be distributed without Cegedim authorization – Copyright 2014 8
Slide 9: Next Steps on IMS Health Transaction
Next Steps on IMS Health Transaction This document should not be distributed without Cegedim authorization – Copyright 2014 9
Slide 10: IMS Health Transaction: FAQ
IMS Health Transaction: FAQ This document should not be distributed without Cegedim authorization – Copyright 2014 10
Slide 11: Two Different Strategies
Two Different Strategies This document should not be distributed without Cegedim authorization – Copyright 2014 11
Slide 12: New Cegedim: Key Proforma Figures
New Cegedim: Key Proforma Figures Based on FY 2013 proforma figures This document should not be distributed without Cegedim authorization – Copyright 2014 12
Slide 13: Healthcare Professionals Division
Healthcare Professionals Division Based on FY 2013 proforma figures This document should not be distributed without Cegedim authorization – Copyright 2014 13
Slide 14: Cegedim Healthcare Software
Cegedim Healthcare Software Based on 2013 figures This document should not be distributed without Cegedim authorization – Copyright 2014 14
Slide 15: Insurance & Services Division
Insurance & Services Division Based on FY 2013 proforma figures This document should not be distributed without Cegedim authorization – Copyright 2014 15
Slide 16: Cegedim Assurances
Cegedim Assurances Based on 2013 figures This document should not be distributed without Cegedim authorization – Copyright 2014 16
Slide 17: Cegedim SRH
Cegedim SRH This document should not be distributed without Cegedim authorization – Copyright 2014 17
Slide 18: Cegedim e-business
Cegedim e-business This document should not be distributed without Cegedim authorization – Copyright 2014 18
Slide 19: GERS Activities & Reconciliation Division
GERS Activities & Reconciliation Division Based on FY 2013 proforma figures This document should not be distributed without Cegedim authorization – Copyright 2014 19
Slide 20: Seismic Changes in Healthcare
Seismic Changes in Healthcare This document should not be distributed without Cegedim authorization – Copyright 2014 20
Slide 21: Cegedim Will Remain on Attractive Markets
Cegedim Will Remain on Attractive Markets This document should not be distributed without Cegedim authorization – Copyright 2014 21
Slide 22: Cegedim Strengths
Cegedim Strengths This document should not be distributed without Cegedim authorization – Copyright 2014 22
Slide 23: Financial Performance
Financial Performance ma cegedim
Slide 24: Seasonality and Currency Impact on Business
Seasonality and Currency Impact on Business This document should not be distributed without Cegedim authorization – Copyright 2014 24
Slide 25: 9M-2014 Balance Sheet
9M-2014 Balance Sheet This document should not be distributed without Cegedim authorization – Copyright 2014 25
Slide 26: New Cegedim Proforma Capex
New Cegedim Proforma Capex This document should not be distributed without Cegedim authorization – Copyright 2014 26
Slide 27: Debt Situation
Debt Situation This document should not be distributed without Cegedim authorization – Copyright 2014 27
Slide 28: 9M-2014 Figures
9M-2014 Figures This document should not be distributed without Cegedim authorization – Copyright 2014 28
Slide 29: FY 2014 Outlook
FY 2014 Outlook This document should not be distributed without Cegedim authorization – Copyright 2014 29
Slide 30: Next Events
Next Events This document should not be distributed without Cegedim authorization – Copyright 2014 30
Slide 31: 2015 Financial Agenda
2015 Financial Agenda This document should not be distributed without Cegedim authorization – Copyright 2014 31
Slide 32: Our IR App is now available
Our IR App is now available This document should not be distributed without Cegedim authorization – Copyright 2014 32
Slide 33: First Nine Months 2014 Financial Situation
First Nine Months 2014 Financial Situation
Slide 34: First 9M 2014 Takeaways
First 9M 2014 Takeaways This document should not be distributed without Cegedim authorization – Copyright 2014 34
Slide 35: CRM & Strategic Data Review
CRM & Strategic Data Review Significantly negative currency impact Positive impact on EBITDA from: • Compliance activities • OneKey database-related products Improvement of Profitability of market research activity improved during the first 9 months This document should not be distributed without Ce
Slide 36: Healthcare Professionals Review
Healthcare Professionals Review • Less demanding comparison level for UK doctors software • Margin improvement in software for pharmacists activity in France in Q3 • Robust growth in France in products for paramedical professions (nurses, etc.) • Positive development of RNP activity This document sh
Slide 37: Insurance & Services Review
Insurance & Services Review • Transition from a perpetual license model to a SaaS model at Cegedim Global Payments • Significant investment in Kadrige • Profitability increase thanks to: • Activity for Health Insurance companies • Cegedim SRH This document should not be distributed without Cegedim a
Slide 38: GERS Activities & Reconciliation Review
GERS Activities & Reconciliation Review Favorable trend in EBITDA reflects the virtual stability of corporate costs and the gradual return to breakeven at GERS activities This document should not be distributed without Cegedim authorization – Copyright 2014 38
Slide 39: From Revenue to EBITDA
From Revenue to EBITDA This document should not be distributed without Cegedim authorization – Copyright 2014 39
Slide 40: From EBITDA to EBIT
From EBITDA to EBIT This document should not be distributed without Cegedim authorization – Copyright 2014 40
Slide 41: From EBIT to Net Profit
From EBIT to Net Profit This document should not be distributed without Cegedim authorization – Copyright 2014 41
Slide 42: Net Debt Trend
Net Debt Trend This document should not be distributed without Cegedim authorization – Copyright 2014 42
Slide 43: Thank you.
Thank you. We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer Head of Investor Relations Janeryk.umiastowski@cegedim.com www.cegedim.com/finance TEL: +33 (0) 1 49 09 33 36